Cited by 276Metabolism, Diabetes, and CancerPeroxisome Proliferator-Activated ReceptorsAdipose Tissue and Metabolism

Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues

LeBrasseur, Nathan K., Kelly, Meghan, Tsao, Tsu-Shuen, Farmer, Stephen R., Saha, Asish K., Ruderman, Neil B., Tomas, Eva·2006·American Journal of Physiology-Endocrinology and Metabolism

Abstract

Thiazolidinediones (TZDs) are insulin-sensitizing agents used in the treatment of type 2 diabetes. A widely held view is that their action is secondary to transcriptional events that occur when TZDs bind to the nuclear receptor PPARgamma in the adipocyte and stimulate adipogenesis. It has been proposed that this increases insulin sensitivity, at least in part, by increasing the expression and release of adiponectin, an adipokine that activates the fuel-sensing enzyme AMP-activated protein kinase (AMPK). In this study, we report that TZDs also acutely activate AMPK in skeletal muscle and other tissues by a mechanism that is likely independent of PPARgamma-regulated gene transcription. Thus incubation of isolated rat EDL muscles in medium containing 5 microM troglitazone for 15 min (too brief to be attributable to transcription) significantly increased pAMPK and pACC. At a concentration of 100 microM, troglitazone maximally increased these parameters and caused twofold increases in 2-deoxy-d-glucose uptake and the oxidation of exogenous [(14)C]palmitate. Time course studies revealed that troglitazone-induced increases in pAMPK and pACC abundance at 15 min were paralleled by an increase in the AMP-to-ATP ratio and that by 60 min all of these parameters had returned to baseline values. Increases in pAMPK and pACC were also observed in skeletal muscle, liver, and adipose tissue in intact rats 15 min after the administration of a single dose of troglitazone (10 mg/kg, ip). Likewise, troglitazone and another TZD, pioglitazone, caused rapid increases in pAMPK and pACC of equal magnitude in Swiss 3T3 fibroblasts with and without sufficient PPARgamma to mediate the expression of target genes. The results indicate that TZDs can act within minutes to activate AMPK in mammalian tissues. They suggest that this effect is associated with a change in cellular energy state and that it is not dependent on PPARgamma-mediated gene transcription.

Integrity signals

Registry

Crossref · 10.1152/ajpendo.00453.2005

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
LeBrasseur, N. K., Kelly, M., Tsao, T.-S., Farmer, S. R., Saha, A. K., Ruderman, N. B., & Tomas, E.
Affiliations
  • Boston University (US)
  • Whitehead Institute for Biomedical Research (US)
Venue
American Journal of Physiology-Endocrinology and Metabolism
Published
2006-07
Volume
291
Issue
1
Pages
E175-E181
ISSN
  • 0193-1849 (ISSN-L)
  • 1522-1555
OpenAlex
W2107333702
Cited by
276
References
50
Citations by year
2026: 3 · 2025: 6 · 2024: 3 · 2023: 9 · 2022: 8 · 2021: 14 · 2020: 12 · 2019: 10 · 2018: 12 · 2017: 7 · 2016: 11 · 2015: 15 · 2014: 18 · 2013: 16 · 2012: 21
FWCI
10.34
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Physiology-Endocrinology and Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01dk019514-35)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK58825, DK-49147, T32DK007201, DK-19514, DK-007201-28, DK51586, R01DK049147)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
Keywords
thiazolidinediones, AMPK, troglitazone, pioglitazone, skeletal muscle, cellular energy state, insulin sensitivity, type 2 diabetes, adiponectin, ACC phosphorylation, glucose uptake, fatty acid oxidation
MeSH terms
Troglitazone, Acetyl-CoA Carboxylase, Adenosine Diphosphate, Adenosine Monophosphate, Adenosine Triphosphate, Animals, Chromans, Enzyme Activation, Fatty Acids, Glucose, Hypoglycemic Agents, Male, Multienzyme Complexes, Oxidation-Reduction, Rats, Sprague-Dawley, Protein Serine-Threonine Kinases, Muscle, Skeletal, Swiss 3T3 Cells, Thiazolidinediones, PPAR gamma, Mice, Rats, AMP-Activated Protein Kinases, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review